Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3003 | Plasma Donation Wiki | 1.00 |
| drug1247 | Distilled water Wiki | 1.00 |
| drug2147 | Listerine Mouthwash Product Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D010608 | Pharyngeal Diseases NIH | 1.00 |
| D014777 | Virus Diseases NIH | 0.11 |
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
In this pilot trial, 150 confirmed COVID-19 individuals will be randomly assigned to 1 of 5 groups: distilled water, CloSYS (Rowpar Pharmaceutical Inc., USA), Oral-B Mouth Sore (Oral-B, USA), Crest Pro-Health Multi-Protection (Crest, USA), or Listerine (Johnson and Johnson, USA). Study participants will be asked to rinse/gargle with 10ml (2 teaspoons) of the assigned solutions 4 times per day, for 30 seconds, for 4 weeks.
Description: Change in saliva wash RT-PCR SARS-Cov-2 viral load
Measure: Change in SARS-Cov-2 viral load Time: Baseline to 4 weeksDescription: Change in self-reported (questionnaire) clinical symptom onset. A symptom checklist will include: cough, runny nose, scratchy/sore throat, fever, chills, fatigue, muscle ache, shortness of breath, diarrhea/nausea/vomiting, loss of taste/smell, and red /painful eye.
Measure: Change in self-reported clinical symptom onset Time: Baseline to 4 weeksDescription: Change in healthcare utilization and hospitalization
Measure: Change in healthcare utilization and hospitalization Time: Baseline to 4 weeksDescription: Change in saliva wash RT-PCR SARS-Cov-2 viral load in tobacco users, marijuana smokers, or vapers
Measure: Change in SARS-Cov-2 viral load in tobacco users, marijuana smokers, or vapers Time: Baseline to 4 weeksDescription: Change in self-reported (questionnaire) clinical symptom onset in tobacco users, marijuana smokers, or vapers. A symptom checklist will include: cough, runny nose, scratchy/sore throat, fever, chills, fatigue, muscle ache, shortness of breath, diarrhea/nausea/vomiting, loss of taste/smell, and red /painful eye.
Measure: Change in self-reported clinical symptom onset in tobacco users, marijuana smokers, or vapers Time: Baseline to 4 weeksDescription: Change in healthcare utilization and hospitalization in tobacco users, marijuana smokers, or vapers
Measure: Change in healthcare utilization and hospitalization in tobacco users, marijuana smokers, or vapers Time: Baseline to 4 weeksAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports